Ultrasound Guided Knee Injections in Musculoskeletal Medicine (PRISMM)
Knee Osteoarthritis

About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring knee, osteoarthritis, ultrasound, sonography, injection
Eligibility Criteria
Inclusion Criteria:
- Male or female, age 18 to 90
- Clinician determined need for intra-articular knee injection
- Radiograph confirmed grade 1-4 Kellgren Lawrence osteoarthritis scale
Exclusion Criteria:
- Allergy to contrast dye, shellfish
- Allergy to egg product or hyaluronate
- Allergy to lidocaine
- Localized skin infection at planned site of injection
- Inability to complete follow-up phone call three months following the injection
- Viscosupplementation injection within 6 months of the current evaluation
Sites / Locations
- Andrews Research & Education Foundation
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Sham Comparator
Active Comparator
Sham Comparator
Joint Line Ultrasound
Joint Line Landmark
Suprapatellar Ultrasound Guided
Suprapatellar Landmark
Patients assigned to this group receive a standard medial or lateral joint line injection of Euflexxa aided by ultrasound guidance while sitting up.
Patients assigned to this group receive a standard medial or lateral joint line injection of Euflexxa without ultrasound guidance while sitting up.
Patients assigned to this group receive an injection of Euflexxa while lying down into the suprapatellar pouch aided by ultrasound guidance.
Patients assigned to this group receive an injection of Euflexxa while lying down into the suprapatellar pouch without ultrasound guidance.